InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
T+90 hit rate
60%
T+90 mean return
+16.7%
Across 20 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by SCHEIBLER LUKAS, Directeur de l'Innovation. Officer active across 2 companies, notably Apellis Pharmaceuticals, Inc.. Cumulatively, 25 filings have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €1m. History available since 10 June 2021. The latest transaction was filed on 1 December 2023 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations25 total
10,000 shares@ US$13.8514.1% of flowCommon StockSEC:0001127602-23-028966:0
10,000 shares@ US$60.0060.9% of flowCommon StockSEC:0001127602-23-028966:1
1,756 shares@ US$43.017.8% of flowCommon StockSEC:0001127602-23-023845:0
9,886 shares0Common StockSEC:0000899243-23-005789:0
678 shares@ US$51.213.6% of flowCommon StockSEC:0001127602-23-005162:0
542 shares@ US$52.772.9% of flowCommon StockSEC:0001127602-23-002688:0
2,015 shares@ US$52.0510.7% of flowCommon StockSEC:0001127602-23-002135:0
22,580 shares0Common StockSEC:0001127602-23-001500:0
1,875 shares0Common StockSEC:0001127602-22-016013:0
609 shares@ US$13.850.0001% mcap0.7% of flowCommon StockSEC:0001127602-22-011670:0
3,504 shares@ US$13.850.0008% mcap4.1% of flowCommon StockSEC:0001127602-22-011526:0
11,496 shares@ US$13.850.0027% mcap13.4% of flowCommon StockSEC:0001127602-22-011246:0
720 shares@ US$26.730.0003% mcap1.6% of flowCommon StockSEC:0001127602-22-005041:0
678 shares@ US$47.120.0005% mcap2.6% of flowCommon StockSEC:0001127602-22-004774:0
1,666 shares@ US$46.800.0013% mcap6.4% of flowCommon StockSEC:0001127602-22-004908:0
10,000 shares@ US$13.850.0023% mcap11.3% of flowCommon StockSEC:0001127602-22-004067:0
10,000 shares@ US$13.8511.3% of flowCommon StockSEC:0001127602-22-004067
642 shares@ US$38.590.0004% mcap2.1% of flowCommon StockSEC:0001127602-22-002804:0
642 shares@ US$38.592.1% of flowCommon StockSEC:0001127602-22-002804
26,051 shares0Common StockSEC:0001127602-22-002071:0
26,051 shares0Common StockSEC:0001127602-22-002071
3,021 shares@ US$26.730.0014% mcap6.6% of flowCommon StockSEC:0001127602-22-001964:0
3,021 shares@ US$26.736.6% of flowCommon StockSEC:0001127602-22-001964
3,417 shares@ US$60.0015.7% of flowCommon StockSEC:0001127602-21-019710
3,417 shares@ US$60.000.0032% mcap15.7% of flowCommon StockSEC:0001127602-21-019710:0
25 of 25 declarations
About SCHEIBLER LUKAS
Lukas Scheibler is an executive at Apellis Pharmaceuticals, Inc.
